Toshihiro Nakamura

Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial

Deepak L. Bhatt, Philippe Gabríel Steg, Shamir R Mehta et al. · The Lancet · 2019 · 210 citations · Full text

Medicine, Cardiology, Pharmacotherapy +15

Comparative effects of halothane, enflurane, isoflurane and sevoflurane on function and metabolism in the ischaemic rat heart

Takeshi Oguchi, Satoshi Kashimoto, Tasuku Yamaguchi et al. · British Journal of Anaesthesia · 1995 · 53 citations · Full text

Medicine, Pharmacology, Physiology +13

VEGF‐C and Mortality in Patients With Suspected or Known Coronary Artery Disease

Hiromichi Wada, Masahiro Suzuki, Morihiro Matsuda et al. · Journal of the American Heart Association · 2018 · 44 citations · Full text

Medicine, Cardiology, Clinical Sciences +17

Activation of the tamoxifen derivative metabolite E to form DNA adducts: comparison with the adducts formed by microsomal activation of tamoxifen.

Krisztina Pongracz, Deena Nath Pathak, Toshihiro Nakamura et al. · PubMed · 1995 · 38 citations

Medicine, Pharmacology, Toxicology +16

Distinct Characteristics of VEGF‐D and VEGF‐C to Predict Mortality in Patients With Suspected or Known Coronary Artery Disease

Hiromichi Wada, Masahiro Suzuki, Morihiro Matsuda et al. · Journal of the American Heart Association · 2020 · 36 citations · Full text

Medicine, Cardiology, Clinical Sciences +17